Identification and characterization of trametinib degradation product employing Orbitrap LC-HRMS, and development of a robust, eco-friendly stability indicating method of analysis
Fields of Study & Subjects
Melanoma and MAPK Pathways
Chronic Myeloid Leukemia Treatments
Computational Drug Discovery Methods
Publication details
- Journal / source
- Journal of Pharmaceutical and Biomedical Analysis
- Publisher
- Elsevier BV
- Volume
- 272
- Pages
- 117355–117355
- Publication date
- 17 January 2026
- Language
- EN